165 related articles for article (PubMed ID: 26046525)
1. Increased Specific Labeling of INS-1 Pancreatic Beta-Cell by Using RIP-Driven Cre Mutants with Reduced Activity.
Gong GC; Fan WZ; Li DZ; Tian X; Chen SJ; Fu YC; Xu WC; Wei CJ
PLoS One; 2015; 10(6):e0129092. PubMed ID: 26046525
[TBL] [Abstract][Full Text] [Related]
2. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
4. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
5. The Cre-loxP system: a versatile tool for targeting genes in a cell- and stage-specific manner.
Ray MK; Fagan SP; Brunicardi FC
Cell Transplant; 2000; 9(6):805-15. PubMed ID: 11202567
[TBL] [Abstract][Full Text] [Related]
6. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function.
Lee JY; Ristow M; Lin X; White MF; Magnuson MA; Hennighausen L
J Biol Chem; 2006 Feb; 281(5):2649-53. PubMed ID: 16326700
[TBL] [Abstract][Full Text] [Related]
7. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells.
Tamarina NA; Roe MW; Philipson L
Islets; 2014; 6(1):e27685. PubMed ID: 25483876
[TBL] [Abstract][Full Text] [Related]
9. Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase.
Zhu HZ; Wang W; Feng DM; Sai Y; Xue JL
FEBS Lett; 2006 Aug; 580(18):4346-52. PubMed ID: 16846600
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of Ins1-cre-driver C57BL/6N for exclusive pancreatic beta cell-specific Cre-loxP recombination.
Hasegawa Y; Daitoku Y; Mizuno S; Tanimoto Y; Mizuno-Iijima S; Matsuo M; Kajiwara N; Ema M; Oishi H; Miwa Y; Mekada K; Yoshiki A; Takahashi S; Sugiyama F; Yagami K
Exp Anim; 2014; 63(2):183-91. PubMed ID: 24770644
[TBL] [Abstract][Full Text] [Related]
11. Knockin of Cre Gene at Ins2 Locus Reveals No Cre Activity in Mouse Hypothalamic Neurons.
Li L; Gao L; Wang K; Ma X; Chang X; Shi JH; Zhang Y; Yin K; Liu Z; Shi Y; Xie Z; Zhang WJ
Sci Rep; 2016 Feb; 6():20438. PubMed ID: 26830324
[TBL] [Abstract][Full Text] [Related]
12. Efficient removal of LoxP-flanked genes by electroporation of Cre-recombinase mRNA.
Van den Plas D; Ponsaerts P; Van Tendeloo V; Van Bockstaele DR; Berneman ZN; Merregaert J
Biochem Biophys Res Commun; 2003 May; 305(1):10-5. PubMed ID: 12732189
[TBL] [Abstract][Full Text] [Related]
13. Neural expression of alpha-internexin promoter in vitro and in vivo.
Wang P; Wang SM; Hsieh CJ; Chien CL
J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
[TBL] [Abstract][Full Text] [Related]
14. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.
Srinivas S; Watanabe T; Lin CS; William CM; Tanabe Y; Jessell TM; Costantini F
BMC Dev Biol; 2001; 1():4. PubMed ID: 11299042
[TBL] [Abstract][Full Text] [Related]
15. Ins1-Cre and Ins1-CreER Gene Replacement Alleles Are Susceptible To Silencing By DNA Hypermethylation.
Mosleh E; Ou K; Haemmerle MW; Tembo T; Yuhas A; Carboneau BA; Townsend SE; Bosma KJ; Gannon M; O'Brien RM; Stoffers DA; Golson ML
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32267917
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
17. Rat insulin promoter 2-Cre recombinase mice bred onto a pure C57BL/6J background exhibit unaltered glucose tolerance.
Fex M; Wierup N; Nitert MD; Ristow M; Mulder H
J Endocrinol; 2007 Sep; 194(3):551-5. PubMed ID: 17761894
[TBL] [Abstract][Full Text] [Related]
18. Generation and Characterization of Transgenic Mice Expressing Mouse Ins1 Promoter for Pancreatic β-Cell-Specific Gene Overexpression and Knockout.
Cheng Y; Su Y; Shan A; Jiang X; Ma Q; Wang W; Ning G; Cao Y
Endocrinology; 2015 Jul; 156(7):2724-31. PubMed ID: 25885930
[TBL] [Abstract][Full Text] [Related]
19. Reporter alleles that inform on differences in Cre recombinase expression.
Klinger M; Chmura SA; Killeen N
J Immunol; 2010 Jun; 184(11):6170-6. PubMed ID: 20427774
[TBL] [Abstract][Full Text] [Related]
20. Temporally controlled site-specific mutagenesis in the germ cell lineage of the mouse testis.
Weber P; Schuler M; Gérard C; Mark M; Metzger D; Chambon P
Biol Reprod; 2003 Feb; 68(2):553-9. PubMed ID: 12533419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
